Inhibition of hepatocellular carcinoma by PegIFNα-2a in patients with chronic hepatitis C: a nationwide multicenter cooperative study

Namiki Izumi(Musashino Red Cross Hospital), Hiromitsu Kumada(Toranomon Hospital)

Journal of Gastroenterology

August 8, 2012

10.1007/s00535-012-0641-9

Cited by 21

Related Papers

Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma

|New England Journal of Medicine|2008|1.3k

Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial

|Gut|2019|720

Phase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinoma

|European Journal of Cancer|2011|573

A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians

|Nature Genetics|2009|523

Efficacy of lamivudine for preventing hepatocellular carcinoma in chronic hepatitis B: A multicenter retrospective study of 2795 patients

|Hepatology Research|2005|192